Ponzo Giancarlo, Umana Giuseppe Emmanuele, Giuffrida Massimiliano, Furnari Massimo, Nicoletti Giovanni Federico, Scalia Gianluca
Department of Neurosurgery, Highly Specialized Hospital of National Importance "Garibaldi," Catania, Italy.
Department of Neurosurgery, Cannizzaro Hospital, Catania, Italy.
Surg Neurol Int. 2020 Jun 13;11:152. doi: 10.25259/SNI_259_2020. eCollection 2020.
Intramedullary spinal cord metastases represent 4-8.5% of the central nervous system metastases and affect only 0.1-0.4% of all patients. Those originating from renal cell carcinoma (RCC) are extremely rare. Of the eight patients described in the literature with metastatic RCC and intramedullary cord lesion, only five were found in the cervical spine. Here, the authors add a 6 case involving an RCC intramedullary metastasis at the C1-C2 level.
A 78-year-old male patient presented with intermittent cervicalgia of 5 months duration accompanied by few weeks of a progressive severe right hemiparesis, up to hemiplegia. The magnetic resonance imaging (MRI) examination revealed an intramedullary expansive lesion measuring 10 mm×15 mm at the C1-C2 level; it readily enhanced with contrast. A total body computed tomography (CT) scan documented an 85 mm mass involving the right kidney, extending to the ipsilateral adrenal gland, and posteriorly infiltrating the ipsilateral psoas muscle. The subsequent CT-guided fine-needle biopsy confirmed the diagnosis of an RCC (Stage IV). The patient next underwent total surgical total removal of the C1-C2 intramedullary mass, following which he exhibited a slight motor improvement, with the right hemiparesis (2/5). He died after 14 months due to global RCC tumor progression.
The present case highlights that a patient without a prior known diagnosis of RCC may present with an intramedullary C1-C2 metastasis. In such cases, global staging is critical to determine whether primary lesion resection versus excision of metastases (e.g., in this case, the C1-C2 intramedullary tumor) are warranted.
脊髓髓内转移瘤占中枢神经系统转移瘤的4 - 8.5%,仅累及所有患者的0.1 - 0.4%。源自肾细胞癌(RCC)的此类转移瘤极为罕见。在文献报道的8例伴有髓内脊髓病变的转移性RCC患者中,仅5例位于颈椎。在此,作者补充1例C1 - C2水平的RCC髓内转移病例。
一名78岁男性患者,有5个月间歇性颈部疼痛病史,伴有数周进行性加重的严重右侧偏瘫,直至半身不遂。磁共振成像(MRI)检查显示C1 - C2水平有一个10 mm×15 mm的髓内膨胀性病变,增强扫描后明显强化。全身计算机断层扫描(CT)显示右肾有一个85 mm的肿块,延伸至同侧肾上腺,并向后浸润同侧腰大肌。随后的CT引导下细针穿刺活检确诊为RCC(IV期)。该患者随后接受了C1 - C2髓内肿块的全切除手术,术后运动功能稍有改善,右侧偏瘫(肌力2/5级)。14个月后,患者因RCC肿瘤广泛进展死亡。
本病例突出表明,既往无RCC诊断的患者可能出现C1 - C2髓内转移。在此类病例中,全面分期对于确定是否有必要切除原发灶或转移灶(如本病例中的C1 - C2髓内肿瘤)至关重要。